Evidence map›Paper›PMID 35994082›Full record

ArticleUrolithiasis2022

How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?

Isabelle N Tostivint, Vincent Castiglione, Rana Alkouri, Jean Philippe Bertocchio, Rachida Inaoui, Michel Daudon, Marie-Paule Dousseaux, Etienne Cavalier, Laurence Pieroni, Hassan Izzedine

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Isabelle N TostivintDepartment of Nephrology, AP-HP, Pitie Salpetriere Hospital, 48 Boulevard de l'Hôpital, 75013, Paris, France. isabelle.tostivint@aphp.fr.ORCID http://orcid.org/0000-0002-2263-9820
Vincent CastiglioneDepartment of Clinical Chemistry, University Hospital of Liege, Liege, Belgium.
Rana AlkouriDepartment of Metabolic Biochemistry, AP-HP, Pitie Salpetriere Hospital, Paris, France.
Jean Philippe BertocchioDepartment of Nephrology, AP-HP, Pitie Salpetriere Hospital, 48 Boulevard de l'Hôpital, 75013, Paris, France.
Rachida InaouiDepartment of Rheumatology, AP-HP, Pitie Salpetriere Hospital, Paris, France.
Michel DaudonDepartment of Biochemistry, Cristal Laboratory, AP-HP, Tenon Hospital, Paris, France.
Marie-Paule DousseauxDepartment of Nutrition and Dietetics, AP-HP, Pitie Salpetriere Hospital, Paris, France.
Etienne CavalierDepartment of Clinical Chemistry, University Hospital of Liege, Liege, Belgium.
Laurence PieroniDepartment of Metabolic Biochemistry, AP-HP, Pitie Salpetriere Hospital, Paris, France.
Hassan IzzedineDepartment of Nephrology, Peupliers Private Hospital, Paris, France.
Sorbonne Université · FRUniversity of Liège · BERamsay Santé Hôpital privé des Peupliers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercalciuria is the main risk factor for recurrent calcium urolithiasis. The goal of our study is to determinate how useful an oral calcium load test is for stone formers to classify different forms of hypercalciuria in pathogenetic categories defined as renal or absorptive according to the current knowledge. Between June 2013 and February 2016, a prospective study was carried out on 117 documented recurrent hypercalciuric stone formers undergoing an oral calcium load test modified from the original description by Pak. After 2 days of calcium-restricted diet, urine and blood were analyzed at baseline and 120 min after receiving orally 1 g of calcium. Total and ionized calcium, parathyroid hormone from serum and urine calcium and creatinine were assessed in order to divide patients in three groups as previously described: resorptive, absorptive, and renal hypercalciuria. This allowed the identification of 19, 39, 34 and 33 patients with normocalcemic primary hyperparathyroidism (NPHPT), renal hypercalciuria aka renal calcium leak (RCL), absorptive hypercalciuria (AH) and unidentified cause, respectively. Patients with NPHPT (who required parathyroidectomy) experienced a lower PTH decrease (41.41 ± 12.82 vs. 54.06 ± 13.84% p < 0.01), higher beta-crosslaps, as well as lower TmP/GFR and distal third radius bone mineral density. RCL resulted in increased fasting urine calcium-to-creatinine ratio (Uca/Cr), i.e., > 0.37 mmol/mmol), without hyperparathyroidism. AH was diagnosed by the presence of ΔUCa/Cr > 0.60 mmol/mmol between baseline and 120 min without any other anomaly. For all remaining patients, results were inconclusive due to the lack of sufficient increase in serum calcium or because the cause of lithogenesis could not be clearly identified. The oral calcium load test is useful in nearly 80% of patients by identifying the different forms of hypercalciuria causing urolithiasis and by guiding treatment, including parathyroid surgery.

Indexed as

Kidney CalculiUrolithiasisCalciumCalcium, DietaryCreatinineHumansHypercalciuriaProspective StudiesCalciumCalcium, DietaryCreatinineCalcium hyperabsorptionHypercalciuriaKidney stoneNormocalcemic hyperparathyroidismOral calcium loadPak testPrimary hyperparathyroidismRenal calcium leak

Identifiers

PMID35994082
OpenAlexW4292608126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.